Ausgabe 1/2019
Inhalt (4 Artikel)
Update on Risankizumab for Psoriasis
Jennifer C. Bares, Mark G. Lebwohl
Tildrakizumab for Moderate-to-Severe Chronic Plaque Psoriasis: a Review of the Literature
Kory P. Schrom, Avi Bitterman, Neil J. Korman
Nanotechnology for Psoriasis Therapy
Emily C. Murphy, Samuel W. Schaffter, Adam J. Friedman
Biosimilars for Psoriasis—Experience from Europe
Arnon D. Cohen, Tiago Torres, Wolf-Henning Boehncke, Menno de Rie, Denis Jullien, Luigi Naldi, Caitriona Ryan, Robert Strohal, Lone Skov, Peter van de Kerkhof, Joelle M. van der Walt, Jashin J. Wu, Claus Zachariae, Lluis Puig, Helen Young